From obesity to diabetes

被引:34
作者
Keller, Ulrich [1 ]
机构
[1] Univ Basel Hosp, Div Endocrinol Diabet & Clin Nutr, CH-4031 Basel, Switzerland
关键词
fatty acids; adipocytes; metabolic syndrome; adiponectin; inflammation; diabetes type 2 prevention;
D O I
10.1024/0300-9831.76.4.172
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The prevalence of obesity has been increasing dramatically in the last decades in the whole world, not only in industrialized countries but also in developing areas. A major complication of obesity is insulin resistance and type 2 diabetes. Diabetes is also rapidly increasing world-wide-reaching a prevalence in adults of approx. 5-6% in Central Europe and in the US, and more than 50% in specific, genetically prone populations. This article re views pathogenetic mechanisms linking obesity and type 2 diabetes. Emphasis is placed on the observation that excessive amounts of adipocytes are associated with an impairment of insulin sensitivity, a key feature of the "metabolic syndrome". This is a cluster of metabolic abnormalities such, astype 2 diabetes, hypertension and dyslipidemia; all of them are enhanced by the presence of visceral (abdominal ) obesity and all contribute to the increased cardiovascular risk observed in these patients. Beside's release of free fatty acids, adipocytes secrete substances that contribute to peripheral insulin resistance, including adiponectin, resistin 1, TNF-alpha and interleukin 6. Increased turnover of free fatty acids interferes with intracellular metabolism of glucose in the muscle, and they exert lipotoxic effect on pancreatic P-cells. The prereceptor metabolism of cortisol is enhanced in visceral adipose tissue by activation of I I P-hydroxysteroid dehydrogenase type 1. A new class of anti-diabetic drugs (thiazolidinediones, or glitazones) bind to peroxisome proliferator activated receptor (PPAR-gamma) and lower thereby plasma free fatty acids and cytokine production in adipocytes, in addition to a decrease of resistin and an increase in adiponectin observed in animals, resulting in an overall, increase in insulin sensitivity and in an improvement of glucose homeostasis. However, the first step to avoid insulin resistance and prevent the development of diabetes, should be a reduction in body weight in overweight, subjecs, and an,increase in physical activity. There are now three published randomized controlled trials demonstrating that in high risk individuals, life style changes with modest weight lost, associated with diminished fat intake and an increase in fruit and vegetable consumption result in marked inhibition of the transition from the prediabetic-state to manifest type 2 diabetes.
引用
收藏
页码:172 / 177
页数:6
相关论文
共 29 条
  • [1] AMER P, 2003, TRENDS ENDOCRIN MET, V14, P137
  • [2] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [4] WEIGHT AS A RISK FACTOR FOR CLINICAL DIABETES IN WOMEN
    COLDITZ, GA
    WILLETT, WC
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    ARKY, RA
    SPEIZER, FE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (03) : 501 - 513
  • [5] Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
    Hotamisligil, GS
    Arner, P
    Atkinson, RL
    Spiegelman, BM
    [J]. DIABETES, 1997, 46 (03) : 451 - 455
  • [6] Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
    Hu, FB
    Manson, JE
    Stampfer, MJ
    Colditz, G
    Liu, S
    Solomon, CG
    Willett, WC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 790 - 797
  • [7] Cardiovascular morbidity and mortality associated with the metabolic syndrome
    Isomaa, B
    Almgren, P
    Tuomi, T
    Forsén, B
    Lahti, K
    Nissén, M
    Taskinen, MR
    Groop, L
    [J]. DIABETES CARE, 2001, 24 (04) : 683 - 689
  • [8] Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ
    Iwata, M
    Haruta, T
    Usui, I
    Takata, Y
    Takano, A
    Uno, T
    Kawahara, J
    Ueno, E
    Sasaoka, T
    Ishibashi, O
    Kobayashi, M
    [J]. DIABETES, 2001, 50 (05) : 1083 - 1092
  • [9] Janssen I, 2004, AM J CLIN NUTR, V79, P379
  • [10] Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in man
    Keller, U
    Turkalj, I
    Laager, R
    Bloesch, D
    Bilz, S
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (06): : 754 - 760